Gilead faces an increasing number of lawsuits claiming it sold inferior HIV drugs to maximize profits, while sitting on safer formulas which minimized the risks of kidney and liver injuries.…
A group of more than 40 plaintiffs say Gilead unnecessarily marketed toxic HIV drugs which caused kidney and bone injuries while sitting on a safer alternative in order to maximize patent protection profits.…
Lawsuits allege that side effects of Truvada, Viread, Atripla, Complera and Stribild may have been avoided if the manufacturer had not withheld safer versions of the HIV drugs as part of a scheme to maximize profits.…
A lawsuit by nearly 30 plaintiffs accuses Gilead of delaying the sale of safer HIV drugs to maximize profits at the expense of patient safety.…
A federal judge has cleared the way for a Truvada lawsuit which claims Gilead held back data indicating its HIV drugs could cause kidney damage from doctors and regulators.…
A lawsuit filed by 30 plaintiffs claims Gilead knew its line of HIV drugs, including Truvada and Stribild, were more toxic than alternatives it had already developed before the first drugs were sold.…
A new injection drug may be safer and more effective at preventing HIV than Truvada, according to clinical trials.…
A lawsuit filed by 10 plaintiffs claims Gilead sat on a safer formulation of HIV drugs, but sold inferior, more dangerous products in order to maximize profits.…
A new study and HIV drug recommendations highlights the safety differences between newer and older Gilead HIV medications.…
Gilead faces a class action lawsuit over claims it bribed a generic competitor into not releasing its own version of the Truvada HIV drug.…
